Cover Image
市場調查報告書

幹細胞銀行的全球市場:2018年∼2022年

Global Stem Cell Banking Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 341748
出版日期 內容資訊 英文 113 Pages
訂單完成後即時交付
價格
Back to Top
幹細胞銀行的全球市場:2018年∼2022年 Global Stem Cell Banking Market 2018-2022
出版日期: 2018年01月02日 內容資訊: 英文 113 Pages
簡介

關於幹細胞銀行

全球幹細胞銀行業務市場與全球再生醫療市場息息相關。再生醫學是現代醫學的一個重要分支,已經成為組織工程和分子生物學的結合體。再生醫學旨在重新設計人體細胞,組織或器官,以取代或恢復受損細胞,組織或器官的正常功能。

Technavio的分析師預測,全球幹細胞銀行市場將以,從2018年到2222年期間12.76%的年複合成長率成長。

本報告提供全球幹細胞銀行市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模與預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 市場區隔:各細胞類型

  • 概要
  • 比較:各細胞類型
  • 成體幹細胞
  • 臍帶血幹細胞
  • 胚胎幹細胞
  • 市場機會:各細胞類型

第8章 客戶形勢

第9章 地區形勢

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 無機的成長策略的強化
  • 定做醫藥品需求高漲
  • 幹細胞療法的接納擴大

第13章 業者情勢

  • 競爭模式

第14章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • AMAG Pharmaceuticals
  • Cordlife
  • Cryo-Cell International
  • Esperite
  • 其他有力的供應商

第15章 附錄

  • 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR20140

About Stem Cell Banking

The global stem cell banking market is a closely related market to the global regenerative medicine market. Regenerative medicine is a key branch of modern medicine, which has emerged as a combination of tissue engineering and molecular biology. Regenerative medicine aims to re-engineer human cells, tissues, or organs, which can replace or restore the normal functioning of impaired cells, tissues; or organs.

Technavio's analysts forecast the global stem cell banking market to grow at a CAGR of 12.76% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global stem cell banking market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Stem Cell Banking Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AMAG Pharmaceuticals
  • Cordlife
  • Cryo-Cell International
  • Esperite

Other Prominent Vendors

  • Cellular Dynamics International
  • China Cord Blood Corporation
  • Cordvida
  • Cryo Stemcell
  • Cryoviva India
  • Cytori Therapeutics
  • Lifecell
  • PerkinElmer
  • Reelabs
  • Smart Cells International
  • Stemade Biotech
  • StemCyte

Market driver

  • Growing prevalence of cancer
  • For a full, detailed list, view our report

Market trend

  • Growing acceptance of stem cell therapies
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY CELL TYPE

  • Overview
  • Comparison by cell type
  • Adult stem cells
  • Umbilical cord blood stem cells
  • Embryonic stem cells
  • Market opportunity by cell type

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Stem cell banking market in Americas
  • Stem cell banking market in EMEA
  • Stem cell banking market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing implementation of inorganic growth strategies
  • Rising demand for personalized medicines
  • Growing acceptance of stem cell therapies

PART 13: VENDOR LANDSCAPE

  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AMAG Pharmaceuticals
  • Cordlife
  • Cryo-Cell International
  • Esperite
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global stem cell banking market: Related market
  • Exhibit 02: Global stem cell banking market: Market characteristics
  • Exhibit 03: Global stem cell banking market: Market segments
  • Exhibit 04: Market definition: Inclusions and exclusions checklist
  • Exhibit 05: Global stem cell banking market: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Global stem cell banking market: Market size and forecast 2017-2022 ($ billions)
  • Exhibit 08: Global stem cell banking market: Year-over-year growth 2017-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of suppliers
  • Exhibit 12: Threat of new entrants
  • Exhibit 13: Threat of substitutes
  • Exhibit 14: Threat of rivalry
  • Exhibit 15: Market condition: Five forces 2017
  • Exhibit 16: Market condition: Five forces 2022
  • Exhibit 17: Global stem cell banking market: Segmentation by cell type 2017-2022 (% share)
  • Exhibit 18: Global stem cell banking market: Comparison by cell type
  • Exhibit 19: Global adult stem cell banking market 2017-2022 ($ billions)
  • Exhibit 20: Global adult stem cell banking market: Year-over-year growth 2018-2022 (%)
  • Exhibit 21: Global umbilical cord blood stem cell banking market 2017-2022 ($ billions)
  • Exhibit 22: Global umbilical cord blood stem cell banking market: Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Global embryonic stem cell banking market 2017-2022 ($ billions)
  • Exhibit 24: Global embryonic stem cell banking market: Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Global stem cell banking market: Market opportunity by cell type
  • Exhibit 26: Global stem cell banking market: Customer landscape
  • Exhibit 27: Global stem cell banking market: Segmentation by geography 2017-2022 (% share)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Stem cell banking market in Americas 2017-2022 ($ billions)
  • Exhibit 30: Stem cell banking market in Americas: Year-over-year growth 2018-2022 (%)
  • Exhibit 31: Top three countries in Americas
  • Exhibit 32: Stem cell banking market in EMEA 2017-2022 ($ billions)
  • Exhibit 33: Stem cell banking market in EMEA: Year-over-year growth 2018-2022 (%)
  • Exhibit 34: Top three countries in EMEA
  • Exhibit 35: Stem cell banking market in APAC 2017-2022 ($ billions)
  • Exhibit 36: Stem cell banking market in APAC: Year-over-year growth 2018-2022 (%)
  • Exhibit 37: Top three countries in APAC
  • Exhibit 38: Cancer severity across EU in 2013 and cancer incidence in US in 2014
  • Exhibit 39: Year-over-Year growth and growth rate of stem cell research spending in US 2013-2016 ($ billions)
  • Exhibit 40: CIRM funding in stem cell research 2014 ($ billions)
  • Exhibit 41: CIRM active programs 2014
  • Exhibit 42: EC funding for regenerative medicine
  • Exhibit 43: Strategic success factors of vendors in market
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: AMAG Pharmaceuticals: Overview
  • Exhibit 47: AMAG Pharmaceuticals: Business segments
  • Exhibit 48: AMAG Pharmaceuticals: Organizational developments
  • Exhibit 49: AMAG Pharmaceuticals: Geographic focus
  • Exhibit 50: AMAG Pharmaceuticals: Segment focus
  • Exhibit 51: AMAG Pharmaceuticals: Key offerings
  • Exhibit 52: Cordlife: Overview
  • Exhibit 53: Cordlife: Business segments
  • Exhibit 54: Cordlife: Organizational developments
  • Exhibit 55: Cordlife: Geographic focus
  • Exhibit 56: Cordlife: Segment focus
  • Exhibit 57: Cordlife: Key offerings
  • Exhibit 58: Cryo-Cell International: Overview
  • Exhibit 59: Cryo-Cell International: Business segments
  • Exhibit 60: Cryo-Cell International: Organizational developments
  • Exhibit 61: Cryo-Cell International: Geographic focus
  • Exhibit 62: Cryo-Cell International: Segment focus
  • Exhibit 63: Cryo-Cell International: Key offerings
  • Exhibit 64: Esperite: Overview
  • Exhibit 65: Esperite: Business segments
  • Exhibit 66: Esperite: Organizational developments
  • Exhibit 67: Esperite: Geographic focus
  • Exhibit 68: Esperite: Segment focus
  • Exhibit 69: Esperite: Key offerings
Back to Top